New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir.
about
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelinePurification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitorsApplications of computer-aided approaches in the development of hepatitis C antiviral agents.Daclatasvir (Daklinza): A Treatment Option for Chronic Hepatitis C Infection.The therapeutic potential of new investigational hepatitis C virus translation inhibitors.Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience.Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation; a Japanese multicenter experience.Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases.
P2860
Q28076883-A1583328-B80F-47D8-815B-74FA0C9D7357Q28223065-8DFDC997-434C-4654-8706-6A34CF3C4AA0Q30238530-CA1734C1-1043-4E78-A680-92E10CEEDAC2Q37462851-E3559248-EF62-4925-BC8D-85329735CA5DQ38930861-53388CBD-2100-4754-B7F3-25207763068FQ39099569-8CF38AFA-1741-4A75-ABC3-CAAFB98A850EQ40044312-B81CEDE0-618E-420C-A4E3-22E1124E9E84Q40053650-3BAF35B4-687D-4906-8AB2-848B9FA3C0DCQ47112883-F55F6509-628A-4CF6-BF73-327D6EAACE49
P2860
New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
New direct-acting antivirals i ...... vir, ombitasvir and dasabuvir.
@en
type
label
New direct-acting antivirals i ...... vir, ombitasvir and dasabuvir.
@en
prefLabel
New direct-acting antivirals i ...... vir, ombitasvir and dasabuvir.
@en
P2860
P50
P1476
New direct-acting antivirals i ...... vir, ombitasvir and dasabuvir.
@en
P2860
P304
P356
10.1586/17512433.2016.1129272
P407
P577
2015-12-10T00:00:00Z